Table 1.
Population characteristics of IW dogs summarized by treatment. Data are reported in frequencies or medians (interquartile range)
| Variable | Treatment Groups (PPS n = 66) | P‐value | ||
|---|---|---|---|---|
| Pimobendan (n = 23) | Benazepril (n = 22) | Methyldigoxin (n = 21) | ||
| Age (years)* | 4.5 (3.3,5.8) | 3.4 (2.5,5.0) | 4.0 (2.8,4.5) | .257 |
| Sex (F/FC/M/MC) | 11/1/11/0 | 7/0/15/0 | 6/2/13/0 | .365 |
| Body weight (kg)* | 70.0 (62.0,75.0) | 68.5 (62.0,74.0) | 70.0 (63.0,75.0) | .782 |
| Diltiazem (n) | 2 | 3 | 3 | .805 |
| AF (%) | 8 (34.8%) | 6 (27.3%) | 6 (28.6%) | .843 |
| DCM (%) | 15 (65.2%) | 16 (72.7%) | 15 (71.4%) | .843 |
| DCM with AF (%) | 9 (60.0%) | 12 (75.0%) | 9 (60.0%) | .59 |
| DCM with sinus arrhythmia (%) | 6 (40.0%) | 4 (25.0%) | 6 (40.0%) | .59 |
PPS, per protocol dataset; F, female; FC, female neutered; M, male; MC, male castrated; AF, atrial fibrillation; DCM, dilated cardiomyopathy; *Median (interquartile range).